Clinical data | |
---|---|
Pronunciation | /traɪˈmɛθəprɪm/ |
Trade names | Proloprim, Monotrim, Triprim, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684025 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Diaminopyrimidines |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 90–100% |
Protein binding | 44% |
Metabolism | Liver |
Elimination half-life | 8–12 hours |
Excretion | Kidney (50–60%), faeces (4%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
PDB ligand | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.915 |
Chemical and physical data | |
Formula | C14H18N4O3 |
Molar mass | 290.323 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Trimethoprim (TMP) is an antibiotic used mainly in the treatment of bladder infections.[1] Other uses include for middle ear infections and travelers' diarrhea.[1] With sulfamethoxazole or dapsone it may be used for Pneumocystis pneumonia in people with HIV/AIDS.[1][2] It is taken orally (swallowed by mouth).[1]
Common side effects include nausea, changes in taste, and rash.[1] Rarely it may result in blood problems such as not enough platelets or white blood cells.[1] Trimethoprim may cause sun sensitivity.[1] There is evidence of potential harm during pregnancy in some animals but not humans.[3] It works by blocking folate metabolism via dihydrofolate reductase in some bacteria, preventing creation of bacterial DNA and RNA and leading to bacterial cell death.[1]
Trimethoprim was first used in 1962.[4] It is on the World Health Organization's List of Essential Medicines.[5] It is available as a generic medication.[6]